Reversibly paralyzing and heavily sedating hospitalized patients with severe breathing problems do not improve outcomes in most cases, according to an NIH-funded clinical trial conducted at dozens of North American hospitals and led by clinician-scientists at Pitt -- including Derek Angus (BCHS '92), chair of critical care medicine and distinguished professor of health policy and management -- and the University of Colorado.
Four Pitt Public Health students have been selected as 2019-20 Pittsburgh Schweitzer Fellows. Inngide Osirus and Dzigbordi Kamasa-Quashie of IDM and Yamira Bell and Ariel Snell of the MMPH program will participate for a full year of experiential learning and direct service addressing the needs of disadvantaged citizens in southwest Pennsylvania. John Cordier (HPM '19) recently graduated from the Fellowship.
LA TIMES - Los Angeles County officials dealing with a measles outbreak say they expect that more people will be diagnosed with the illness in the coming weeks, while the nation stares down what will like be its worst measles year in decades. As they search for outbreak's start, HPM and PHDL's Mark Roberts reminds us, "What matters is not the case that started it, what matters is how many people that one case infects."
On April 27, 2019, Pitt Public Health celebrated recent graduates with awards given upon the culmination of a degree program. Delta Omega's honor society inductees were announced and outstanding thesis/essay and dissertation awards were conferred. Outstanding Student Awards were also given at both the master's and doctoral level, as well as Dean's Service Awards.
MANAGED CARE - Pitt Med's Derek Angus (BCHS '92) contributed to a first-of-its-kind, hematology-based cellular biomarker that is designed to help emergency department physicians identify patients with sepsis or who are at increased risk of developing sepsis. Compared to the traditional method of reviewing white blood cell count alone, the Early Sepsis Indicator strengthens a clinician’s suspicion of sepsis by 43 percent.
Inmaculada Hernandez (HPM ’16) is assistant professor in the Pitt School of Pharmacy. She earned her PharmD degree and a master's in health economics in Spain and completed her PhD at Pitt Public Health in three years. She has earned multiple academic awards as she continues her career in the health services of pharmaceutical polices, culminating in being named one of Forbes magazine’s 30 Under 30 in Healthcare in 2019.
WGCU NEWS - With measles outbreaks on the rise and vaccination rates falling in some places, HPM and PHDL's Mark Roberts discusses our latest simluator, FRED Measles Florida shows how quickly this preventable disease could spread if vaccination rates were to drop by 15%, highlighting the importance of herd immunity.
Congratulations to Dean's Day winners in the master's category. Receiving first place is Beth Hoffman (BCHS ‘23). Second place was awarded to Kevin Stoner (HPM ‘19). Third place was given to K evin Sullivan (EPI ‘19).
Krista Grobelny (MPH '22) won the master's level award and Mara Hollander (PhD '19) won the doctoral level award.
SSM Health has named Steven M. Scott (HADM '85) as president after he's served as interim president since January. In this role, he is responsible for leading the 356-bed academic medical center that specializes in organ transplant, advanced cancer therapies, and trauma services.
US NEWS & WORLD REPORT- In the 2020 rankings of best graduate schools, Pitt's Master of Health Administration (MHA) program surged from 29th to 17th nationally among programs in health care management. The move was one of the largest in the country, positioning the Pitt MHA as the highest-ranked program in the Commonwealth of Pennsylvania.
MINNESOTA PUBLIC RADIO - Americans spend more on prescription drugs than anyone else in the world, a fact attributed to the ever rising costs of pharmaceuticals. HPM's Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing, discusses a recent Congressional hearing, in which pharmaceutical executives claim that their hands are tied by the current health care system, and that they need profits to fund new research.
NPR - "With the current awareness and the bipartisan agreement in the recognition of drug prices as a major concern, we are in an optimal environment for the design and implementation of policies targeted at controlling prices, and assuring the affordability of medications to the U.S. public,” states Inmaculada Hernandez (HPM '16). "Financial barriers for medication…are having a detrimental effect on our fellow citizens' health."
PITT WIRE - A recent study led by Inmaculada Hernandez (HPM '16), assistant professor of pharmacy and therapeutics, found that new drugs entering the market drive up prices, but drug companies are also hiking prices on older drugs.
FOX NEWS - "It's not about innovation, it's about inflation in existing products," explains Inmaculada Hernandez (HPM '16). "They are the same companies that operate in other countries and they don't show this behavior and that's because in other countries they are lucky to have this regulatory environment that prevents them from doing this."